• Vaccines, Ema starts continuous review for Sputnik

  • Vaccini, Dompè: "Initial problems were foreseeable, soon we will have many serums"

  • Vaccines.

    An administration for those who have had Covid

  • Government, Draghi hears von der Leyen: accelerate on vaccines

  • Mise meeting: 'Producing anti-covid vaccines in Italy from autumn'

Share

04 March 2021 "I believe that there are elements, despite a situation of great concern, that outline a future for us as regards the supply and production of vaccines on an Italian and European basis that can inspire confidence".

This was stated by the Minister of Economic Development, Giancarlo Giorgetti, at the end of the meeting with the European Commissioner Thierry Breton, on vaccines against Covid.

"An important meeting to define Italy's strategy with the European Commission" added Giorgetti.



Breton: "At the end of the year 2-3 billion produced in Europe"


At the end of the year we will have a production capacity of vaccines in Europe between 2 and 3 billion a year, while the United States will be about 2.5 billion.

Europe will be the first continent in terms of production. "The EU commissioner for the internal market with responsibility for vaccines, Thierry Breton, said at the end of a meeting with Development Minister Giancarlo Giorgetti. The other countries are detached, he added: "Russia is unable and China is far behind.


" "No country in terms of vaccines can be defined as autonomous, all countries are interdependent", commented Breton, head of the vaccine task force.



Farmindustria: within end of year vaccine production in Italy


"Minister Giorgetti has expressed his desire to collaborate with the pharmaceutical industry to ensure that Italy can also make a contribution to the production of vaccines.

We are trying to understand which bioreactors are available in Italy and how many are there.

We are evaluating these factors to implement this strategic production plan by the end of the year ". Massimo Scaccabarozzi, president of Farmindustria, told" The Breakfast Club "on Radio Capital." It is not a problem that can be solved in a few days , it takes time to adapt the machines but Italy must be part of this European production network because it has an industry of excellence.

Many say that the productions are late, but in reality it is the vaccines that have arrived early.

Nobody would have expected them to be available in such a short time. "" In September, I believe that the problem of the lack of vaccines will be solved, but this commitment of the pharmaceutical industry must not be reduced at the moment Covid.

This may not be the last pandemic and we must be prepared in this field. "As president Janssen, of the Johnson & Johnson group, Massimo Scaccabarozzi returns to the approval of the Johnson & Johnson vaccine:" We await the approval of our vaccine.

In the meantime, we are making an incredible rush to keep our commitments and supply Europe by the end of the year with 200 million doses ". And on the possibility of vaccinating everyone first with a single dose to speed up the times, Scaccabarozzi disagrees:" You can't improvise, if the research has given you some indications you have to respect them ".